NL-OMON42070
Withdrawn
Not Applicable
Clinical validation of a dried blood spot (DBS) method for the analysis of rifampicin (RIBOD study). - RIBOD
niversitair Medisch Centrum Sint Radboud0 sites10 target enrollmentTBD
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- analysis of drugs used for tuberculosis
- Sponsor
- niversitair Medisch Centrum Sint Radboud
- Enrollment
- 10
- Status
- Withdrawn
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* Patients aged 18 or over
- •\* Treated at the Radboud University Centre for Chronic Diseases Dekkerswald
- •\* Treated with rifampicin
- •\* The drug concentration being in steady state
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical validation of a dried blood spot (DBS) method for the analysis of immunosuppressive and antifungal drugs in pediatric patients (part of the PROTECT study).immuunsuppressie na niertransplantatieanalysis of drug used in renal transplantation / analysis of drug used in invasive fungal infections10017528NL-OMON44369Afdeling Apotheek89
Completed
Not Applicable
Clinical validation of the Dry Blood Spot (DBS) method for risperidone, aripiprazole, pipamperone and its major metabolitesnvt10013511NL-OMON45799Erasmus MC, Universitair Medisch Centrum Rotterdam120
Completed
Not Applicable
Clinical validation of the Dry Blood Spot (DBS) method for risperidone, aripiprazole, pipamperone and its major metabolitesantipsychotics, pipamperone, aripiprazole, paliperidone, risperidoneNL-OMON28955Erasmus MC Medical Center60
Completed
Not Applicable
Clinical validation of the dried blood spot analysis for antituberculosis drugsBlood concentration of anti TB drugs10028440NL-OMON34891niversitair Medisch Centrum Groningen33
Recruiting
Not Applicable
Clinical evaluation of dried blood spots for the determination of ribociclib blood levelsNL-OMON25336ovartis20